obesity drug glp-1 news today weight loss drugs leave users low on key nutrients, study finds glp-1 obesity drugs news today

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

doi: 10.1016/j.metop.2022.100220

2 Medications reviewed included: semaglutide, dulaglutide, tirzepatide, lixisenatide, liraglutide, and exenatide

Key Takeaways MedVi charges $199$299/month for compounded GLP-1 medications through its online telehealth platform, with no insurance accepted Several alternatives cost less: Enhance.MD starts at $49 for the first month, Yucca Health from $169/month, and T-Mates offers no-hidden-fee flat pricing Insurance-friendly options exist: Found Health (free insurance check) and PlushCare work with health insurance, potentially saving $50$200+/month All providers offer compounded or brand-name GLP-1s: Semaglutide and tirzepatide are the most commonly prescribed across platforms Research-grade peptides offer another path: For laboratory and research use, GLP-1 compounds are available at significantly lower cost MedVi has grown into one of the more visible telehealth platforms for GLP-1 weight loss prescriptions, serving over 500,000 patients through its online portal and generating $1.6 billion in first-year sales

While industry proponents will frame Ozempic, Rybelsus and Wegovy as three new products and inventions (or innovations), all three rely on the exact same active ingredient

Subgroup analyses were performed to explore efficacy differences in receptor specificity